Therefore, we note that we identified differential methylation of single CpG sites within 7/59, two CpG sites in 2/59 (BCL11A, AKT2), and consistent changes in six CpG sites in 1/59 (KCNQ1) type-2 diabetes genes [15]. The gene discussed is AKT2; the disease is type 2 diabetes mellitus.